Stock 4171 GENEREACH BIOTECHNOLOGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News GeneReach Biotechnology Corp.

Equities

4171

TW0004171004

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
32.2 TWD -1.08% Intraday chart for GeneReach Biotechnology Corp. +5.40% -18.38%
Mar. 28 GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
GeneReach Biotechnology Corp.(TPEX:4171) dropped from S&P Global BMI Index
CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
GeneReach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
GeneReach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Taiwan's OBI Pharma Grants Experimental Drug Rights to Odeon Therapeutics (Hong Kong)
MT
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Genereach Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Genereach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Genereach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Genereach Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
GeneReach Biotechnology Corp.(GTSM:4171) added to S&P Global BMI Index
CI
Genereach Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020
CI
Genereach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
Genereach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4171 Stock
  4. News GeneReach Biotechnology Corp.